Top U.S. market share of SNRIs based on revenue 2013

This statistic displays the top serotonin-norepinephrine reuptake inhibitors (SNRIs) based on total U.S. revenue market share in 2013. In that year, Pristiq was among the leading SNRIs with a market share of 9.7 percent based on SNRI revenues in the United States. SNRIs are a type of antidepressant drug used to treat major depression disorder or other mood disorders. They can also be used for anxiety disorders, obsessive-compulsive disorder, and other related disorders.

Top SNRIs based on U.S. revenue market share in 2013*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2014


United States

Survey time period


Supplementary notes

* SNRI: Serotonin-norepinephrine reuptake inhibitor.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.